![](/img/cover-not-exists.png)
Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis
Warren, Marshelle S, Hughes, Steven G, Singleton, Walter, Yamashita, Mason, Genovese, Mark CVolume:
17
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-015-0578-5
Date:
December, 2015
File:
PDF, 253 KB
english, 2015